<DOC>
	<DOCNO>NCT00442858</DOCNO>
	<brief_summary>The aim present study therefore two-fold : 1 ) make retrospective comparison incidence non-fatal stroke cardiac event large cohort patient confirm GHD replacement therapy ( include GH ) control cohort general population ; 2 ) compare prevalence DM cardioprotective medication cohort time questionnaire distribution adjustment possible confounders effect modifier .</brief_summary>
	<brief_title>Incidence Cardiovascular Diseases Patients With Hypopituitarims</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Confirmed GH deficiency Not confirm GH deficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>cardiac disease</keyword>
	<keyword>cerebrovascular disease</keyword>
	<keyword>GH deficiency</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>hypertension</keyword>
	<keyword>GH therapy</keyword>
	<keyword>GH deficiency hypopituitarims</keyword>
</DOC>